MeiraGTx Holdings MGTX
NASDAQ MGTX
$13.89 -0.08 (-0.57%)
As of: Sep 4, 2026 · 3:59 PM EDT

MeiraGTx Holdings (MGTX) Cash from Investing Activities (2017 - 2025)

MeiraGTx Holdings' (MGTX) quarterly Cash from Investing Activities came in at -$1.1 million in Q4 2025, up 10.59% YoY from -$984708.2 in Q4 2024, and down 99.09% on a QoQ basis from -$547000.0 in Q3 2025.

Analysis

MeiraGTx Holdings (MGTX) Cash from Investing Activities (2017 - 2025) Analysis & Trends

MeiraGTx Holdings (MGTX) has 9 years of Cash from Investing Activities data on file, last reported at -$1.1 million in Q4 2025.

  • Quarterly Cash from Investing Activities rose 10.59% year-over-year to -$1.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$4.1 million (down 117.49% YoY) and the FY2025 annual result came in at -$4.1 million, down 117.49% from the prior year.
  • Cash from Investing Activities fell to -$1.1 million in Q4 2025, from -$547000.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $51.2 million in Q4 2023 to a low of -$25.4 million in Q4 2021.
  • A 5-year average of -$2.7 million and a median of -$4.3 million in 2023 frame the typical range for Cash from Investing Activities.
  • Annual changes were most pronounced in 2021 — Cash from Investing Activities sank 367.49% — and 2023, when it jumped 702.66%.
  • Tracing MGTX's Cash from Investing Activities over 5 years: stood at -$25.4 million in 2021, then soared by 66.53% to -$8.5 million in 2022, then jumped by 702.66% to $51.2 million in 2023, then plunged by 102.38% to -$1.2 million in 2024, then climbed by 10.59% to -$1.1 million in 2025.
  • The last three Cash from Investing Activities figures came in at -$1.1 million (Q4 2025), -$547000.0 (Q3 2025), and -$761000.0 (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -45.80 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -92.70 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 329.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -1.66 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -49.35 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -363.46 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -229.72 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 24.51 Mn
10 MeiraGTx Holdings 1.27 Bn 1.13 Bn 315.67 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -1.09 Mn
Sep 30, 2025 -547,000.00
Jun 30, 2025 -761,000.00
Mar 31, 2025 -1.71 Mn
Dec 31, 2024 -1.22 Mn
Sep 30, 2024 -1.31 Mn
Jun 30, 2024 -1.33 Mn
Mar 31, 2024 27.34 Mn
Dec 31, 2023 51.18 Mn
Sep 30, 2023 -3.56 Mn
Jun 30, 2023 -4.98 Mn
Mar 31, 2023 -8.61 Mn
Dec 31, 2022 -8.49 Mn
Sep 30, 2022 -10.01 Mn
Jun 30, 2022 -14.00 Mn
Mar 31, 2022 -12.46 Mn
Dec 31, 2021 -25.37 Mn
Sep 30, 2021 -11.91 Mn
Jun 30, 2021 -5.58 Mn
Mar 31, 2021 -18.87 Mn